APTINYX INC.

APTX NASDAQ
2.950
-0.170
-5.45%
盘后: 2.950 0 0.00% 16:23 06/14 EDT
开盘
3.120
昨收
3.120
最高
3.130
最低
2.940
成交量
19.79万
成交均量(3M)
36.66万
52周最高
32.25
52周最低
2.880
换手率
0.63%
市值
9,283.52万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供APTINYX INC. APTX股票价格,APTINYX INC.股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Aptinyx Inc. is a clinical-stage biopharmaceutical company. The Company discovers and develops therapies for disorders of the brain and nervous system. The Company has a platform for discovering compounds that work through a mechanism, which includes modulation of the N-methyl-D-aspartate (NMDA) receptor to develop pathways involved with nerve cell communication. The Company's compounds are effective on disease models including, depression, neuropathic pain, migraine, traumatic brain injury and age-induced learning impairment. The Company's compounds facilitate receptor activation without over-activating the receptor. The Company’s lead product candidate is NYX-2925, a treatment for the painful diabetic peripheral neuropathy. It is also developing NYX-783 for the treatment of post-traumatic stress disorder and NYX-458 for Parkinson’s disease cognitive impairment. The Company in partnership with Allergan plc, develops AGN-241751 for major depressive disorder indications.
展开 >

最近浏览

名称
价格
涨跌幅